It is used in the induction of remission of patients with APL.
2
But I find myself telling him about my daughter, who has APL.
3
What makes APL a little trickier is that it's a chemoresistant disease.'
4
Yet, the application of apelin-13 reversed all these deleterious effects in group APL.
5
The ATRA treatment of APL thus further reinforces the concept of differentiation therapy.
1
Significant seasonal and yearly variations were detected in all diagnosis except the APML.
2
Underlining the risks, fighting was reported near APML's concession area three days after it announced its license in October.
3
APML's concession surrounds the Bawdwin mine, which CEO Andrew Mooney said was the world's largest source of lead and zinc in the 1930s.
1
Overall, 795 patients with acutepromyelocyticleukemia were enrolled in this trial.
2
However, no such significant elevation was observed in patients with acutepromyelocyticleukemia.
3
Repression by nuclear receptors plays important roles in acutepromyelocyticleukemia and other diseases.
4
When they returned the next Monday, they would hear the news: Their coach had acutepromyelocyticleukemia.
5
The authors conclude that this single course consolidation of ATRA-induced remission provides excellent long-term control of acutepromyelocyticleukemia.
Uso de promyelocytic leukemia em inglês
1
Overall, 795 patients with acute promyelocyticleukemia were enrolled in this trial.
2
However, no such significant elevation was observed in patients with acute promyelocyticleukemia.
3
Repression by nuclear receptors plays important roles in acute promyelocyticleukemia and other diseases.
4
Acute promyelocyticleukemia still relapsed, typically about three to four months after treatment with trans-retinoic acid.
5
When they returned the next Monday, they would hear the news: Their coach had acute promyelocyticleukemia.
6
The authors conclude that this single course consolidation of ATRA-induced remission provides excellent long-term control of acute promyelocyticleukemia.
7
The system described here may also serve as a model for studying the pathogenesis of human acute promyelocyticleukemia.
8
Objective: To investigate molecular mechanism of tanshinone II A inducing differentiation and apoptosis in acute promyelocyticleukemia NB4 cells.
9
Strong TCR signaling during T-CD4 T-cell development correlates with the expression of the transcription factor promyelocyticleukemia zinc finger protein.
10
Thrombosis of the cerebral veins or sinuses is a rare cerebrovascular disorder, which seldom represents a complication of acute promyelocyticleukemia.
11
In addition, co-treatment with adenanthin and VD3 was able to induce differentiation in other non-acute promyelocyticleukemia cells and primary leukemia cells.
12
All-trans retinoic acid (RA) is the first highly effective differentiation-inducing agent for remission induction in patients with acute promyelocyticleukemia.
13
Patients: Two pediatric patients (an 11-yr-old male and a 12-yr-old female) affected by acute promyelocyticleukemia.
14
Such RA-dependent phosphorylation was also observed in primary acute promyelocyticleukemia cells and resulted in activation of the kinase domain of PKC delta.
15
In this study three components of early response to TGF-beta1 treatment were investigated in human promyelocyticleukemia HL-60 cells.
16
A 29-year-old Japanese woman at the 27th gestational week was diagnosed with acute promyelocyticleukemia and underwent all-trans retinoic acid therapy.